期刊文献+

宫颈鳞癌组织中PD-ECGF C-erbB-2Cath-D的表达及临床意义 被引量:1

The Studies on Expression of PD-ECGF, C-erbB-2 and Cath-D inCervical Squamous Cell Carcinoma and Clinical Significance
下载PDF
导出
摘要 目的:探讨PD-ECGF、C-erbB-2和Cath-D三种蛋白在宫颈鳞癌中表达的临床意义及其相关性。方法:应用免疫组化法检测87例宫颈鳞癌组织及23例对照组中PD-ECGF、C-erbB-2和Cath-D的表达,采用!2检验,分析三种蛋白表达与临床病理参数的关系。结果:1)PD-ECGF在宫颈鳞癌中表达率高且与临床分期及组织分化程度有关;2)C-erbB-2在宫颈鳞癌中的表达率和对照组比较,差异有显著性(P<0.01);表达率与临床分期、组织分化程度有显著相关性(P<0.05);3)Cath-D的阳性表达率高于对照组,其表达与宫颈鳞癌组织分化程度、淋巴结转移相关;4)C-erbB-2与Cath-D之间阳性表达有显著相关性(P<0.05)。结论:PD-ECGF、C-erbB-2及Cath-D可作为判断宫颈鳞癌生物学行为的重要指标。 Objective: To investigate the expression of PD-ECGF, C-erbB-2 and Cath-D in cervical squamous cell carcinoma and their clinical significance and relationship among them. Methods: By using immunohistochemistry to detect PD-ECGF, C-erbB-2 and Cath-D in 87 cases of cervical squamous cell carcinoma and 23 samples of dysplasia of cervical epithelium and normal cervical tissues. The relationship between their expression with clinicopathologic factors was analyzed by chisquare test. Results: 1) The expression rates of PD-ECGF are in connection with cellular differentiation and cervical squamous cell carcinoma of clinical stage. 2) The expression rate of C-erbB-2 elevated paralleling the escalation of the clinical stage and the cellular differentiation of cervical carcinoma (P〈 0.05). 3) The expression rate of Cath-D was in connection with cellular differentiation and lymph nodes metastasis (P〈0.05). 4) There was a relationship between expression of C-erb B-2 and Cath-D (P〈0.05). Conclusion: The result suggests that the expression of PD-ECGF, C-erbB-2 and of Cath-D are closely related to growth, invasion and metastasis of the cervical squamous cell carcinoma.
作者 于黎明 胡蓉
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第23期1345-1348,共4页 Chinese Journal of Clinical Oncology
基金 宁夏回族自治区自然科学基金资助(编号:A4019)
关键词 宫颈鳞癌 PD-ECGF C-ERBB-2 CATH-D Cervical squamous cell carcinoma PD-ECGF C-erbB-2 Cath-D
  • 相关文献

参考文献10

  • 1Hale RJ, Buckley CJ, Fox H, et al. Prognostic value of C-erbB-2expression in uterine cervical carcinoma [J]. Clin Pathol, 1992, 45(7) :594 -596
  • 2Garcia M, Deroc D, Pujol P, et al. Overexpression of transfected cathepsin-D in transformed cells increases their malignant phenotype and metastatic potency[J]. Oncogene, 1990, 5(12):1809-1816
  • 3罗衡桂,杨竹林,丁应文,李永国,马铁祥,王力,王云.胰腺癌中三种血管生长因子受体的表达研究[J].中华消化杂志,2002,22(8):467-469. 被引量:9
  • 4于黎明,胡蓉.宫颈鳞癌组织中PD-ECGFmRNA与PD-ECGF的表达及临床意义[J].实用妇产科杂志,2005,21(3):151-153. 被引量:3
  • 5Re lf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-l, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis[J]. Cancer Res, 1997, 57(5):963-969
  • 6Tokumo K, Kodama J, Seki N, et al. Different angiogenic pathways in human cervical cancers [J]. Gynecol Oncol, 1998, 68(1):38-44
  • 7Bacus SS, Chin D, Yanden Y, et al. Type lreception tyrosine kinases are differentially phosphorylated receptors [J]. Am J Pathol,1996, 148(2):549-558
  • 8Vignon F, Capony F, Chambon M, et al. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein[J]. Endocrinology, 1986, 118(4) :1537 - 1545
  • 9Wu GS, Saftig P, Peters C, Ei-Deiry WS. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivety[J]. Oncogene, 1998, 16(17):2177-2183
  • 10Kristensen GB, Holm R, Abeler VM, et al. Evaluation of the prognostic significance of cathepsin D, Epidermal Growth Factor Receptor, and C-erbB-2 in early cervical squamous cell carcinoma[J]. Cancer, 1996, 78(3): 43-47

二级参考文献15

  • 1杨竹林,李永国,钟德,庄赞根.胰腺癌组织中微血管计数及其意义[J].中华实验外科杂志,1995,12(3):135-136. 被引量:9
  • 2Tokumo K,Kodama J,Seki N,et al.Different angiogenic pathways in human cervical cancers.Gynecol Oncol,1998,68:38.
  • 3Nicholas S.Brown ,Adam Jones,et al.Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.Cancer Res,2000,60:6298.
  • 4Kodam J,Yoshinouchi M,Saeki N,et al.Angiogenesia and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.Int J Oncol,1999,15:149.
  • 5Saeki T,Tanada M,Takashima S,et al.Correlation between expression of platelet-derived endothelial cell growth factor(thymidine phosphorylase)and microveasel density in early-stage human colon carcinomas.Jpn Oncol,1997,27:227.
  • 6Robert W.Jyung,MD;Elizabeth E.Leclair,et al.Expression of angiogenic growth factors in paragangliomas.The Laryngoscope,2000,110:161.
  • 7Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer, 1999, 79:1553-1563.
  • 8Holmgren L. Antiangiogenesis restricted tumor dormancy. CancerMetastasis Rev, 1996,15: 241-245.
  • 9Asahara T, Bauters C, Zheng L P, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor onangiogenesis in vivo. Circulation, 1995,92(9 suppl):365 371.
  • 10Fujimoto K, Hosotani R, Wada M, et al. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, andits relationship to angiogenesis. Eur J Cancer, 1998, 34:14391447.

共引文献9

同被引文献9

  • 1Leonce S, Kraus-Berthier L, Golsteyn RM, et al.Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1[J]. Cancer Res, 2006, 66(14):7203--7210.
  • 2Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004[J]. GA Cancer J Clin, 2004, 54(1):8-29.
  • 3Chen DJ, Nirodi CS. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage[]]. Clin Cancer Res, 2007, 13(22 Pt 1): 6555-6560.
  • 4Mass RD. The HER receptor family: a rich target for therapeutic development[J]. Int J Radiat Oncol Biol Phys, 2004, 58(3): 932-940.
  • 5Sato S, Kajiyama Y, Sugano M, et al. Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein[]]. IntJ Radiat Oncol Biol Phys, 2005, 61(1): 203-211.
  • 6Fukutome M, Maebayashi K, Nasu S, et al. Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin")[J]. Int J Radiat Oncol Biol Phys, 2006, 66(2): 528--536.
  • 7ContessaJN, AbeU A, Valerie K, et al. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells[J]. Int J Radiat Oncol Biol Phys, 2006, 65(3): 851-858.
  • 8Price DJ, Avraham S, Jiang S, et al. Role of the aging vasculamre and Erb B--2 signaling in epidermal growth factor---dependent in- travasion of breast carcinoma cells[J]. Cancer, 2004, 101(1): 198-205.
  • 9Collis sJ, DeWeese TL, Jeggo PA, et al. The life and death of DNA-PK[J]. Oncogene, 2005, 24(6): 949--961.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部